Balanced news tone
News Sentiment
TNON sentiment intelligence
Tenon Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-10.8% over one week, -42.5% over four weeks, trend inactive, and below fair value.
Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jul 2026 01:51
- Source
- Ad-hoc-news.de
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 13:10
- Source
- Ad-hoc-news.de
Tenon Medical Regains Nasdaq Compliance on Equity Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 14:10
- Source
- MT Newswires
Tenon Medical regains Nasdaq compliance on equity rule By Investing.com
Tenon Medical Inc. has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million following a $4.2 million public offering of common stock and warrants. The company had previously received a warning from Nasdaq regarding non-compliance. Despite bei
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 20 Jul 2026 14:10
- Source
- Investing.com Nigeria
Tenon Medical regains Nasdaq compliance on equity rule
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 12:09
- Source
- Investing.com
Tenon Medical Regains Nasdaq Stockholders’ Equity Compliance After $4.2M Offering
Tenon Medical has regained compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement following a $4.2 million public offering of common stock and warrants. The company was notified of its compliance on July 17, 2026, but must maintain this status through its
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 20 Jul 2026 12:41
- Source
- TradingView
Tenon Medical regains Nasdaq equity compliance | TNON 8-K Filing
Tenon Medical Inc. (TNON) has regained compliance with Nasdaq's continued listing requirement to maintain at least $2.5 million in stockholders’ equity, as confirmed by a Nasdaq notice on July 17, 2026. This compliance was achieved following a $4.2 million public offering of comm
- Tone
- Positive 62/100
- Event
- Market update
- Published
- 20 Jul 2026 12:40
- Source
- Stock Titan
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement
Tenon Medical, Inc. announced that it has regained compliance with Nasdaq's minimum stockholders' equity requirement. This compliance was achieved through a $4.2 million public offering of common stock and warrants completed on July 1, 2026. However, the company faces potential d
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 20 Jul 2026 11:41
- Source
- ACCESS Newswire
A $4.2M offering helped Tenon Medical meet a Nasdaq rule
Tenon Medical announced it has regained compliance with Nasdaq's $2.5 million stockholders' equity requirement following a $4.2 million public offering of common stock and warrants completed on July 1, 2026. The company received official notification from Nasdaq on July 17, 2026.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 11:40
- Source
- Stock Titan
Tenon Medical (TNON) Proxy filing Summary
Tenon Medical's 2026 Annual Meeting will be held virtually on July 23, 2026, with key proposals including director elections, auditor ratification, a reverse stock split, and approval for debt and future financings. The Board recommends voting in favor of all proposals, citing al
- Tone
- Negative 40/100
- Event
- Regulatory and legal
- Published
- 19 Jul 2026 13:10
- Source
- Quartr
Tenon Medical (TNON) Registration filing Summary
This article summarizes Tenon Medical's (TNON) registration filing, detailing its focus on minimally invasive medical devices for SI joint disorders with products like the Catamaran and SImmetry systems. The company recently expanded its product portfolio through acquisitions and
- Tone
- Negative 38/100
- Event
- Deals and strategy
- Published
- 16 Jul 2026 01:09
- Source
- Quartr
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
[DEFR14A] Tenon Medical, Inc. Revised Proxy Statement
Tenon Medical, Inc. has filed an amendment to its definitive proxy statement (Schedule 14A) correcting errors regarding the required vote for its Reverse Stock Split Proposal. The amendment clarifies that the affirmative vote of a majority of the voting power of shares present or
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 18:10
- Source
- Stock Titan
Tenon Medical Raises Capital, Regains Nasdaq Equity Compliance
Tenon Medical, Inc. (TNON) successfully raised $4.2 million through a public offering on July 1, 2026, selling common stock and warrants, which allowed it to regain compliance with Nasdaq's minimum stockholders' equity requirement by July 10, 2026. This action was taken after the
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 12 Jul 2026 00:11
- Source
- The Globe and Mail
Tenon Medical, Inc. Regains Nasdaq Compliance After $4.2M Public Offering – Form 8-K July 2026 Update
Tenon Medical, Inc. announced it has regained Nasdaq compliance after completing a $4.2 million public offering of common stock and warrants. The company previously received a non-compliance notice in May 2026 for failing to meet minimum stockholders' equity requirements. While t
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 01:10
- Source
- Minichart
Tenon Medical says $4.2M offering restores Nasdaq stockholders' equity compliance
Tenon Medical announced that a $4.2 million public offering of common stock and warrants has brought the company into compliance with Nasdaq's minimum stockholders' equity requirement. Nasdaq will continue to monitor Tenon Medical's compliance, with failure to evidence it by the
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 10 Jul 2026 21:10
- Source
- TradingView
Tenon Medical (TNON) uses $4.2M stock and warrant sale to address Nasdaq equity deficit
Tenon Medical (TNON) has addressed its Nasdaq minimum stockholders’ equity requirement deficit by completing a $4.2 million public offering of common stock and warrants. The company believes this offering, completed on July 1, 2026, brings it into compliance as of July 10, 2026.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 21:10
- Source
- Stock Titan
Tenon Medical (TNON) Q4 2025 earnings summary
Tenon Medical (TNON) reported record full-year 2025 revenue of $3.9 million, a 20% increase year-over-year, driven by strong adoption of its Catamaran and SImmetry+ platforms. The company achieved significant gross profit improvements and secured FDA 510(k) clearance for its SImm
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 08 Jul 2026 22:12
- Source
- Quartr
Tenon Medical (Nasdaq:TNON) - Stock Analysis
Tenon Medical (Nasdaq:TNON) is a medical device company with a market cap of US$4.0m, focused on developing implants for severe lower back pain. The company faces significant risks including shareholder dilution, high stock volatility, unprofitability, and a short cash runway. De
- Tone
- Negative 13/100
- Event
- Balance sheet
- Published
- 08 Jul 2026 21:40
- Source
- Simply Wall Street
Tenon Medical (TNON) joint filing shows reporting persons may hold 4.99% via warrants
A joint SCHEDULE 13G filing by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC indicates they collectively hold a 4.99% beneficial ownership in Tenon Medical (TNON) through warrants. This ownership is capped by a "blocker provision" that prevents exercise if it w
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 20:10
- Source
- Stock Titan
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
WallachBeth Capital LLC announced the closing of Tenon Medical, Inc.'s public offering, raising $4.2 million in gross proceeds. The offering included common stock and common stock purchase warrants, priced at $0.38 per share. Tenon Medical plans to use the net proceeds for partia
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 05 Jul 2026 00:40
- Source
- Barchart.com
Tenon Medical, Inc. Financial Disclosures & SEC Filings
This page provides access to Tenon Medical, Inc.'s SEC filings and other important corporate documents, including Forms 10-K, 10-Q, and 8-K. It allows users to review summaries of earnings calls, press releases, and annual/quarterly reports from 2022 through Q1 FY2026, highlighti
- Tone
- Positive 77/100
- Event
- Earnings
- Published
- 03 Jul 2026 01:09
- Source
- TradingView
Tenon Medical (NASDAQ: TNON) closes $4.2M stock and warrant offering
Tenon Medical (NASDAQ: TNON) has completed a public offering, raising gross proceeds of $4.2 million through the sale of common stock, pre-funded warrants, and common stock purchase warrants at a combined price of $0.38 per share. The company intends to utilize these net proceeds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 19:39
- Source
- Stock Titan
Tenon Medical's Catamaran SI Joint Fusion System Gets FDA 510(k) Clearance; Shares Rise Pre-Bell
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 12:51
- Source
- MT Newswires
Tenon Medical receives FDA clearance for updated SI joint system
Tenon Medical (NASDAQ:TNON) announced it received FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System, which includes instrument upgrades and reclassifies certain instruments from disposable to reusable, aiming to reduce per-procedure costs. Despite this positiv
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 13:10
- Source
- Investing.com
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
Tenon Medical, Inc. announced it has received FDA 510(k) clearance for its Catamaran® SI Joint Fusion System, incorporating instrument upgrades and reclassifying some instruments from disposable to reusable. This clearance is expected to improve the system's performance and provi
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 02 Jul 2026 12:10
- Source
- ACCESS Newswire
Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering
Tenon Medical, Inc. has announced the closing of a public offering that raised $4.2 million in gross proceeds. The offering included 11,052,631 shares of common stock (or pre-funded warrants) along with common stock purchase warrants to acquire up to 13,263,159 shares, priced at
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 02 Jul 2026 09:10
- Source
- Chronicle-Tribune
Tenon Medical, Inc. Warrant 2023-16.06.28 on Tenon Medical Financial Disclosures & SEC Filings
This page provides access to financial disclosures and SEC filings for Tenon Medical, Inc. (TNONW). It lists various quarterly and annual earnings reports, 8-K forms, 10-Q quarterly reports, and 10-K annual reports from 2022 through 2026, summarizing key financial highlights and
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jul 2026 19:09
- Source
- TradingView
Tenon Medical closes $4.2 million public offering
Tenon Medical Inc. has successfully closed a public offering, generating $4.2 million in gross proceeds from the sale of common stock or pre-funded warrants. The company plans to use these funds for partial repayment of convertible notes, expanding its commercial footprint, clini
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 01 Jul 2026 17:09
- Source
- Investing.com
Tenon Medical closes $4.2M stock sale, adds warrants
Tenon Medical Inc. announced the closing of a public offering that raised approximately $4.2 million in gross proceeds. The offering included 11,052,631 common shares (or pre-funded warrants) and Common Warrants for up to 13,263,159 shares, all at a combined price of $0.38 per sh
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 01 Jul 2026 15:40
- Source
- Stock Titan